InMed Pharmaceuticals Inc (INM)
0.2268
-0.02
(-6.67%)
USD |
NASDAQ |
Nov 05, 16:00
0.2268
0.00 (0.00%)
After-Hours: 16:14
InMed Pharmaceuticals Max Drawdown (5Y): 99.95% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 99.95% |
September 30, 2024 | 99.95% |
August 31, 2024 | 99.95% |
July 31, 2024 | 99.93% |
June 30, 2024 | 99.92% |
May 31, 2024 | 99.92% |
April 30, 2024 | 99.92% |
March 31, 2024 | 99.92% |
February 29, 2024 | 99.92% |
January 31, 2024 | 99.92% |
December 31, 2023 | 99.92% |
November 30, 2023 | 99.92% |
October 31, 2023 | 99.90% |
September 30, 2023 | 99.89% |
August 31, 2023 | 99.89% |
July 31, 2023 | 99.89% |
June 30, 2023 | 99.89% |
May 31, 2023 | 99.89% |
April 30, 2023 | 99.89% |
March 31, 2023 | 99.89% |
February 28, 2023 | 99.89% |
January 31, 2023 | 99.89% |
December 31, 2022 | 99.89% |
November 30, 2022 | 99.82% |
October 31, 2022 | 99.80% |
Date | Value |
---|---|
September 30, 2022 | 99.67% |
August 31, 2022 | 99.62% |
July 31, 2022 | 99.42% |
June 30, 2022 | 99.25% |
May 31, 2022 | 98.88% |
April 30, 2022 | 98.88% |
March 31, 2022 | 98.88% |
February 28, 2022 | 98.49% |
January 31, 2022 | 98.32% |
December 31, 2021 | 97.90% |
November 30, 2021 | 97.85% |
October 31, 2021 | 97.76% |
September 30, 2021 | 97.19% |
August 31, 2021 | 96.73% |
July 31, 2021 | 96.07% |
June 30, 2021 | 95.72% |
May 31, 2021 | 95.72% |
April 30, 2021 | 95.61% |
March 31, 2021 | 95.23% |
February 28, 2021 | 95.23% |
January 31, 2021 | 95.23% |
December 31, 2020 | 95.23% |
November 30, 2020 | 95.01% |
October 31, 2020 | 94.79% |
September 30, 2020 | 94.59% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.16%
Minimum
Nov 2019
99.95%
Maximum
Aug 2024
97.59%
Average
98.88%
Median
Mar 2022
Max Drawdown (5Y) Benchmarks
Rimrock Gold Corp | 99.49% |
CeCors Inc | 98.60% |
Venus Concept Inc | 99.86% |
Grace Therapeutics Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -83.41 |
Beta (5Y) | 0.7137 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 89.37% |
Historical Sharpe Ratio (5Y) | -0.8303 |
Historical Sortino (5Y) | -1.581 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.25% |